Journal of Clinical Oncology, Vol 16, 3752-3760, Copyright © 1998 by American Society of Clinical Oncology
Bone mass after treatment for acute lymphoblastic leukemia in childhood
K Nysom, K Holm, KF Michaelsen, H Hertz, J Muller and C Molgaard
Section of Paediatric Haematology, The Juliane Marie Centre, Rigshospitalet, Copenhagen, Denmark. nysom@dadlnet.dk
PURPOSE: To study bone mass after childhood acute lymphoblastic leukemia
(ALL) and determine if reduced bone mass is related to previous therapy or
endocrine status at follow-up. PATIENTS AND METHODS: We studied 95
survivors of childhood ALL who were in first remission a median of 11 years
(range, 3 to 23 years) after diagnosis and who had never been irradiated
outside a cranial field. The bone mass was measured by dual-energy x-ray
absorptiometry. The results were compared with data on 396 local controls.
RESULTS: Adjusted for sex and age, the mean whole-body bone mineral content
(BMC) and bone mineral areal density (BMDA) were both significantly reduced
(0.4 SDs less than the predicted mean value). This was mainly caused by
reduced bone mass in the 33 participants who were aged 19 years or older at
follow-up. In these young adults, the mean height for age, bone area for
height, and BMC for bone area were all significantly reduced. This
indicated that the reduced whole-body bone mass was caused by both reduced
bone size and reduced size-adjusted bone mass. Reduced bone size was
related to previous cranial irradiation. Reduced size-adjusted bone mass
was not significantly related to age at diagnosis or at follow-up, length
of follow-up, cranial irradiation, cumulative dose of methotrexate or
corticosteroids, or endocrine status at follow-up. CONCLUSION: The
whole-body bone mass was reduced 11 years after diagnosis of childhood ALL.
If these abnormalities remain, survivors of childhood ALL will have an
increased risk for osteoporotic fractures later in life.
This article has been cited by other articles:

|
 |

|
 |
 
M Jarfelt, H Fors, B Lannering, and R Bjarnason
Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia
Eur. J. Endocrinol.,
February 1, 2006;
154(2):
303 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Marinovic, S. Dorgeret, B. Lescoeur, C. Alberti, M. Noel, P. Czernichow, G. Sebag, E. Vilmer, and J. Leger
Improvement in Bone Mineral Density and Body Composition in Survivors of Childhood Acute Lymphoblastic Leukemia: A 1-Year Prospective Study
Pediatrics,
July 1, 2005;
116(1):
e102 - e108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. D. Brennan, Z. Mughal, S. A. Roberts, K. Ward, S. M. Shalet, T. O. B. Eden, A. M. Will, R. F. Stevens, and J. E. Adams
Bone Mineral Density in Childhood Survivors of Acute Lymphoblastic Leukemia Treated without Cranial Irradiation
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
689 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Oeffinger and M. M. Hudson
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
CA Cancer J Clin,
July 1, 2004;
54(4):
208 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W H. B Wallace, A. Blacklay, C. Eiser, H. Davies, M. Hawkins, G. A Levitt, and M. E M Jenney
Regular review: Developing strategies for long term follow up of survivors of childhood cancer
BMJ,
August 4, 2001;
323(7307):
271 - 274.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nysom, K. Holm, H. Hertz, J. Muller, K. F. Michaelsen, and C. Molgaard
Bone Mass After Treatment for Acute Lymphoblastic Leukemia in Childhood
J. Clin. Oncol.,
June 1, 2001;
19(11):
2970 - 2971.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. BRENNAN and S M SHALET
Reduced bone mineral density at completion of chemotherapy for a malignany
Arch. Dis. Child.,
October 1, 1999;
81(4):
372a - 372.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Arikoski, J. Komulainen, P. Riikonen, R. Voutilainen, M. Knip, and H. Kröger
Alterations in Bone Turnover and Impaired Development of Bone Mineral Density in Newly Diagnosed Children with Cancer: A 1-Year Prospective Study
J. Clin. Endocrinol. Metab.,
September 1, 1999;
84(9):
3174 - 3181.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Harvey, W. L. Hobbie, S. Shaw, and S. Bottomley
Providing Quality Care in Childhood Cancer Survivorship: Learning From the Past, Looking to the Future
Journal of Pediatric Oncology Nursing,
January 1, 1999;
16(3):
117 - 125.
[Abstract]
[PDF]
|
 |
|
|